bluebird bio, Inc. Operating Lease, Payments
bluebird bio, Inc. reported Operating Lease, Payments of $4.43 million for the 3-month period ending 2025-03-31, per its 10-Q filed 2025-05-14.
Financial Statements › Cash Flow › Other Cash Flow Items
us-gaap:OperatingLeasePayments · last filed 2025-05-14
- bluebird bio, Inc. operating lease, payments for the quarter ending 2025-03-31 was $4.43M, a 55.84% increase year-over-year.
- bluebird bio, Inc. operating lease, payments for the quarter ending 2024-12-31 was $5.88M, a 42.37% decline year-over-year.
- bluebird bio, Inc. operating lease, payments for the quarter ending 2024-09-30 was $7.02M, a 29.76% increase year-over-year.
- bluebird bio, Inc. operating lease, payments for the quarter ending 2024-06-30 was $5.46M, a 21.06% decline year-over-year.
- bluebird bio, Inc. operating lease, payments for fiscal 2024 was $21.20M, a 26.60% decline from fiscal 2023.
- bluebird bio, Inc. operating lease, payments for fiscal 2023 was $28.89M, a 105.28% increase from fiscal 2022.
- bluebird bio, Inc. operating lease, payments for fiscal 2022 was $14.07M, a 38.29% decline from fiscal 2021.
- bluebird bio, Inc. operating lease, payments for fiscal 2021 was $22.80M, a 28.26% increase from fiscal 2020.
| Period end | Operating Lease, Payments 3 month | Operating Lease, Payments 6 month | Operating Lease, Payments 9 month | Operating Lease, Payments 12 month | Operating Lease, Payments 12 month as first filed | Operating Lease, Payments 842 month |
|---|---|---|---|---|---|---|
| 2025-03-31 | $4.43M 10-Q · filed 2025-05-14 | $10.31M derived: sum of 2 quarters · filed 2025-05-14 | $17.33M derived: sum of 3 quarters · filed 2025-05-14 | $22.79M derived: sum of 4 quarters · filed 2025-05-14 | ||
| 2024-12-31 | $5.88M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-27 | $12.90M derived: sum of 2 quarters · filed 2025-03-27 | $18.36M derived: sum of 3 quarters · filed 2025-03-27 | $21.20M 10-K · filed 2025-03-27 | ||
| 2024-09-30 | $7.02M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14 | $12.48M derived: sum of 2 quarters · filed 2024-11-14 | $15.32M 10-Q · filed 2024-11-14 | $25.52M derived: sum of 4 quarters · filed 2025-05-14 | ||
| 2024-06-30 | $5.46M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-09-27 | $8.30M 10-Q · filed 2024-09-27 | $18.50M derived: sum of 3 quarters · filed 2025-05-14 | $23.91M derived: sum of 4 quarters · filed 2025-05-14 | ||
| 2024-03-31 | $2.84M 10-Q · filed 2025-05-14 | $13.04M derived: sum of 2 quarters · filed 2025-05-14 | $18.45M derived: sum of 3 quarters · filed 2025-05-14 | $25.37M derived: sum of 4 quarters · filed 2025-05-14 | ||
| 2023-12-31 | $10.20M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-27 | $15.61M derived: sum of 2 quarters · filed 2025-03-27 | $22.53M derived: sum of 3 quarters · filed 2025-03-27 | $28.89M 10-K · filed 2025-03-27 | ||
| 2023-09-30 | $5.41M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14 | $12.32M derived: sum of 2 quarters · filed 2024-11-14 | $18.69M 10-Q · filed 2024-11-14 | |||
| 2023-06-30 | $6.92M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-09-27 | $13.28M 10-Q · filed 2024-09-27 | ||||
| 2023-03-31 | $6.36M 10-Q · filed 2024-09-13 | |||||
| 2022-12-31 | $14.07M 10-K · filed 2024-09-13 | $51.38M 10-K · filed 2023-03-29 | ||||
| 2021-12-31 | $22.80M 10-K · filed 2023-03-29 | |||||
| 2020-12-31 | $17.78M 10-K · filed 2023-03-29 | $32.10M 10-K · filed 2021-02-23 | ||||
| 2019-12-31 | -$5.28M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-04 | $3.97M derived: sum of 2 quarters · filed 2022-03-04 | $17.20M 10-K · filed 2022-03-04 | $31.03M 10-K · filed 2020-02-18 | ||
| 2019-09-30 | $9.25M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-10-31 | $22.48M 10-Q · filed 2019-10-31 | ||||
| 2019-06-30 | $13.24M 10-Q · filed 2019-08-01 | |||||
| 2019-03-31 | $7.95M 10-Q · filed 2019-05-03 |